Abstract
A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the ‘anti-apoptotic’ human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day−1) for 4 days, increasing gradually to 2 day−1 at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line.
Similar content being viewed by others
References
Al-Rubeai M, Mills D, Emery AN. Electron-microscopy of hybridoma cells with special regard to monoclonal-antibody production. Cytotechnology 1990; 4: 13–28.
Franek F, Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell-culture—evidence for programmed cell-death. FEBS Letters 1991; 284: 285–287.
Mercille S, Massie B. Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnology and Bioengineering 1994; 44: 1140–1154.
Singh RP, Al-Rubeai M, Gregory CD, Emery AN. Cell-death in bioreactors—a role for apoptosis. Biotechnology and Bioengineering 1994; 44: 720–726.
Moore A, Donahue CJ, Hooley J, Stocks DL, Bauer KD, Mather JP. Apoptosis in CHOcell batch cultures—examination by flow cytometry. Cytotechnology 1995; 17: 1–11.
Griffiths JB. Animal-cell culture processes—batch or continuous. Journal of Biotechnology 1992; 22: 21–30.
Al-Rubeai M, Emery AN, Chalder S, Jan DC. Specific antibody productivity and the cell cycle comparisons of batch, continuous and perfusion cultures. Cytotechnology 1992; 9: 85–97.
Avgerinos GC, Drapeau D, Socalow JS, Mao J, Hsiao K, Broeze RJ. Spin filter perfusion system for high-density cell culture production of recombinant urinary type plasminogen-activator in CHO cells. Bio-Technology 1990; 8: 54–58.
Bierau H, Perani A, Al-Rubeai M, Emery AN. A comparison of intensive cell culture bioreactors operating with hybridomas modified for inhibited apoptotic response. Journal of Biotechnology 1998; 62: 195–207.
Jan DCH, Emery AN, Al-Rubeai M. Use of a spin-filter can reduce disdruption of hybridoma cells in a bioreactor. Biotechnology Techniques 1993; 7: 351–356.
Leelavatcharamas V, Emery AN, Al-Rubeai M. Use of cell cycle analysis to characterise growth and interferon-gamma production in perfusion culture of CHO cells. Cytotechnology 1999; 30: 59–69.
Reuveny S, Velez D, Riske F, MacMillan JD, Miller L. Production of monoclonal-antibodies in culture. Developments in Biological Standardization 1985; 60: 185–197.
Yabannavar VM, Singh V, Connelly NV. Mammalian cell retention in a spin filter perfusion bioreactor. Biotechnology and Bioengineering 1992; 40: 925–933.
Mercille S, Massie B. Induction of apoptosis in oxygen-deprived cultures of hybridoma cells. Cytotechnology 1994; 15: 117–128.
Simpson NH, Milner AE, Al-Rubeai M. Prevention of hybridoma cell death by Bcl-2 during suboptimal culture conditions. Biotechnology and Bioengineering 1997; 54: 1–16.
Mercille S, Johnson M, Lemieux R, Massie B. Filtration-based perfusion of hybridoma cultures in protein free medium— reduction of membrane fouling by medium supplementation with DNAse-I. Biotechnology and Bioengineering 1994; 43: 833–846.
Mercille S, Massie B. Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnology and Bioengineering 1999; 63: 529–543.
Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443.
Itoh Y, Ueda H, Suzuki E. Over-expression of Bcl-2, apoptosis suppressing gene—prolonged viable culture period of hybridoma and enhanced antibody-production. Biotechnology and Bioengineering 1995; 48: 118–122.
Suzuki E, Terada S, Ueda H, et al. Establishing apoptosis resistant cell lines for improving protein productivity of cell culture. Cytotechnology 1997; 23: 55–59.
Singh RP, Emery AN, Al-Rubeai M. Enhancement of survivability of mammalian cells by over-expression of the apoptosis-suppressor gene bcl-2. Biotechnology and Bioengineering 1996; 52: 166–175.
Simpson NH, Singh RP, Perani A, Goldenzon C, Al-Rubeai M. In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. Biotechnology and Bioengineering 1998; 59: 90–98.
Simpson NH, Singh RP, Emery AN, Al-Rubeai M. Bcl-2 over-expression reduces growth rate and prolongs G(1) phase in continuous chemostat cultures of hybridoma cells. Biotechnology and Bioengineering 1999; 64: 174–186.
Fassnacht D, Rossing S, Franek F, Al-Rubeai M, Portner R. Effect of Bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media. Cytotechnology 1998; 26: 219–225.
Fassnacht D, Rossing S, Singh RP, Al-Rubeai M, Portner R. Influence of Bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma. Cytotechnology 1999; 30: 95–105.
Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M. Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. Journal of Biotechnology 2000; 79: 147–159.
Tey BT, Singh RP, Piredda L. Piacentini M, Al-Rubeai M. Influence of Bcl-2 on cell death during cultivation of a Chinese Hamster Ovary cell line expressing a chimeric antibody. Biotechnology Bioengineering 2000; 68: 31–43.
Al-Rubeai M, Singh RP, Goldman MH, Emery AN. Death mechanisms of animal-cells in conditions of intensive agitation. Biotechnology and Bioengineering 1995; 45: 463–472.
Mercille S, Johnson M, Lemieux R, Massie B. Filtration-based perfusion of hybridoma cultures in protein free medium— reduction of membrane fouling by medium supplementation with DNAse-I. Biotechnology and Bioengineering 1994; 43: 833–846.
Kroemer G, Dallaporta B, RescheRigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annual Review of Physiology 1998; 60: 619–642.
Tey BT, Singh RP, Al-Rubeai M. Programmed cell death-An overview of apoptosis in cell culture. Asia Pacific Journal of Molecular Biology and Biotechnology 2001; 9(2): 1–28.
Ishaque A, Al-Rubeai M. Role of Ca, Mg and K ions in determining apoptosis and extent of suppression afforded by bcl-2 during hybridoma cell culture. Apoptosis 1999; 4/5: 335–355.
Ishaqe A, Al-Rubeai M. Role of vitamins in determining apoptosis and extent of suppression by bcl-2 during hybridoma cell culture. Apoptosis 2002; 7: 231–239.
Al-Rubeai M, Emery AN. Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. Journal of Biotechnology 1990; 16: 67–85.
Mohan S, Chohan S, Eade J, Lyddiatt A. Molecular integrity of MABs produced by hybridoma cells in batch and continuous flow culture with integrated product recovery. Biotechnology and Bioengineering 1993; 42: 974–986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tey, B.T., Al-Rubeai, M. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity. Apoptosis 9, 843–852 (2004). https://doi.org/10.1023/B:APPT.0000045792.63249.5a
Issue Date:
DOI: https://doi.org/10.1023/B:APPT.0000045792.63249.5a